• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Mills Howard D. Iii was granted 23,681 shares, increasing direct ownership by 47% to 74,391 units (SEC Form 4)

    5/23/25 4:23:14 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Mills Howard D. III

    (Last) (First) (Middle)
    C/O GENWORTH FINANCIAL, INC.
    11011 WEST BROAD STREET

    (Street)
    GLEN ALLEN VA 23060

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    GENWORTH FINANCIAL INC [ GNW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/22/2025 A 23,681.378(1) A $6.9675(2) 74,391.011 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects award of restricted stock units (RSUs) in payment of a portion of the reporting person's annual retainer fee. The RSUs vest on the one-year anniversary of the grant date, and convert to shares of Common Stock upon vesting (unless the reporting person elected to defer receipt of the shares until termination of service as a director or to a future specified year).
    2. Reflects the twenty-day average trading price per share of Common Stock, which was used to determine the number of RSUs granted.
    /s/ David F. Kurzawa, by power of attorney 05/23/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GNW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Genworth Financial upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

    6/18/25 7:44:47 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres. & CEO, CareScout Ins. White Andrea Lynn converted options into 21,892 shares and covered exercise/tax liability with 6,076 shares, increasing direct ownership by 2% to 684,071 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:30:00 PM ET
    $GNW
    Life Insurance
    Finance

    EVP & Chief Financial Officer Upton Jerome T covered exercise/tax liability with 9,701 shares and converted options into 36,486 shares, increasing direct ownership by 6% to 454,773 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:29:08 PM ET
    $GNW
    Life Insurance
    Finance

    EVP & Chief Investment Officer Saltzgaber Kelly A covered exercise/tax liability with 6,195 shares and converted options into 21,892 shares, increasing direct ownership by 30% to 68,272 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:28:05 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    CareScout Expands National Footprint with New Tools to Navigate Long-Term Care

    Nationwide provider network and personalized nurse-led Care Plans give families tools to plan ahead and make informed care decisions CareScout, a growing platform designed to help families navigate aging with greater confidence and ease, has expanded its service offerings nationwide. Families across the country can now access two powerful tools through CareScout: a personalized Care Plan created by a licensed nurse and a credentialed network of home care providers through the CareScout Quality Network. The offerings mark another step forward in CareScout's goal to become a one-stop platform for aging and long-term care – helping people plan and understand, find, and fund care with great

    1/20/26 10:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth Financial Schedules Earnings Conference Call for February 24

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 23, 2026. A conference call will be held on February 24, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 24 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5373572. To participat

    1/8/26 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $GNW
    SEC Filings

    View All

    SEC Form 8-K filed by Genworth Financial Inc

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    2/23/26 4:12:34 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SCHEDULE 13G filed by Genworth Financial Inc

    SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/12/26 9:29:26 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth Financial Inc filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    2/3/26 4:35:21 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Financials

    Live finance-specific insights

    View All

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Schedules Earnings Conference Call for February 24

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 23, 2026. A conference call will be held on February 24, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 24 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5373572. To participat

    1/8/26 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Schedules Earnings Conference Call for November 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 5, 2025. A conference call will be held on November 6, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's November 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #2260685. To participate i

    10/9/25 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $GNW
    Leadership Updates

    Live Leadership Updates

    View All

    CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

    CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

    2/13/24 8:30:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

    RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

    1/4/21 7:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

    SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/13/24 5:06:12 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/9/24 9:59:00 AM ET
    $GNW
    Life Insurance
    Finance